EuroNeoNet (ENN) is a specialized neonatal network to provide networking to European neonatologists and other stakeholders a tool to perform quality assurance and benchmarking, and a framework to facilitate the development of high-quality outcome epidemiological research, implement quality improvement initiatives and randomized clinical trials. ENN is affiliated to the European Society for Paediatric Research and the European Society for Neonatology (ESPR/ESN).

The ENN Mission is to enhance neonatal networking to help neonatologist to promote a culture for quality of care improvements and patient safety, family-centered and developmental care and dissemination of evidence-based interventions, e-learning, and to effectively conduct academically-driven clinical trials, case-control, cohort, cluster and nested studies.

Our Vision statement is that all Very Low-Gestational Age (VLGA, <32 weeks) and Very-Low-Birth-Weight (VLBW, <1500 g) newborn infants born in Europe, receive the best possible health care no matter where born, by preventing any existing inequalities and that all Neonatal Units shear a standardized perinatal risk and protective factors, neonatal interventions and short- and long-term outcomes for those tinny and vulnerable infants.

Our organization values are guided by the democratic, transparency, equal opportunity, values common to the European culture, and to shear all information gathered to help any interested stakeholders.

Our strategic aim is to consolidate a standardized set of health indicators to assess the quality of health care delivered to very premature infants by European institutions, regions and countries. We aim to reduce neonatal morbidity and mortality and improve their health status at 2 years, detect any inequalities that might exist.

Communication to the key interested stakeholders is mainly performed via our interactive website (www.euroneonet.org), but periodic reports, newsletters, leaflets, publications, abstracts and presentations are also periodically and widely disseminated.




The project`s ultimate aim is to achieve better health for mothers and babies by building a European perinatal health surveillance system to provide evidence to policy makers, clinicians and users for informed decision-making. We aim to implement a financially sustainable approach to the production and use of perinatal health data in which (1) core EURO-PERISTAT indicators are included in routine statistical systems through EUROSTAT and ECHIM (European Community Health Indicators Monitoring) and (2) a European Network of experts from participating countries is created to monitor other EURO-PERISTAT indicators and to analyse trends and inequalities in health and care for dissemination to target audiences. The project has 5 specific objectives (1) Integrate EURO-PERISTAT perinatal health indicators into European statistical systems (2)Establish a European Perinatal Health Surveillance Network (3)Develop capacity for high quality health reporting (4)Monitor trends and inequalities in perinatal outcomes and care in Europe (5)Expand EURO-PERISTAT`s geographical coverage.


The project seeks to produce and disseminate a European Perinatal Health Report based on data collected in 2006 in all EU countries which includes policy-relevant analyses of maternal and child health outcomes, care provision, inequalities and migrant health. The project will also develop an Action Plan for Sustainable Perinatal Health Reporting with recommendations about the mission, structure, operation and partners of an information network. Partnership with other EU funded projects will be reinforced.


To provide essential epidemiologic information on congenital anomalies in Europe.
To coordinate the establishment of new registries throughout Europe collecting comparable, standardised data.
To coordinate the detection and response to clusters and early warning of environmental teratogenic exposures.
To evaluate the effectiveness of primary prevention, particularly prevention of neural tube defects and other congenital anomalies by raising peri-conceptional folate status.
To assess the impact of developments in prenatal screening at a population level.
To provide a database and collaborative network for research.
